Dr. Chris Bahl Appointed CEO of AI Proteins
Slice of Healthcare Team
Jan 09, 2025
Key Highlights
- Dr. Chris Bahl, founder and President, now appointed as CEO of AI Proteins.
- Brings expertise in de novo protein design and groundbreaking AI-based drug discovery.
- AI Proteins to present at Biotech Showcase 2025 during JP Morgan Healthcare Conference.
- Innovative platform accelerates creation of therapeutic proteins for unmet medical needs.
Source: Business Wire
Notable Quotes
“ I am honored and excited to take on the role of CEO at this pivotal time for AI Proteins. We have built a remarkable platform with the potential to unlock a new era of protein-based medicines. ”
Dr. Chris Bahl, CEO at AI Proteins
“ Chris' vision and expertise have been instrumental in establishing AI Proteins as a leader in AI-driven protein design. ”
Drew Dennison, Managing Director at Lightchain Capital
